Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 21, 2024EClinicalMedicineOpen Access

Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAlizee BozonnatInsermMBM. Beylot‐BarryUniversité de BordeauxODO. DereureInserm

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bozonnat et al. (2024) studied this question.

synapsesocial.com/papers/68e63c11b6db6435875cdf04https://doi.org/10.1016/j.eclinm.2024.102679
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.20202020 · 122 citations
  2. 2Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients2020 · 147 citations
  3. 3Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study2019 · 238 citations
  4. 4European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 20172017 · 451 citations
  5. 5Infectious events and associated risk factors in mycosis fungoides/Sézary syndrome: a retrospective cohort study2018 · 52 citations